77 related articles for article (PubMed ID: 2914408)
1. The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients.
Ono K
Clin Nephrol; 1989 Jan; 31(1):31-4. PubMed ID: 2914408
[TBL] [Abstract][Full Text] [Related]
2. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
Ono K
Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
6. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
7. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.
Deicher R; Ziai F; Bieglmayer C; Schillinger M; Hörl WH
J Am Soc Nephrol; 2005 Jun; 16(6):1811-8. PubMed ID: 15814831
[TBL] [Abstract][Full Text] [Related]
8. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study].
Peña JM; Logroño JM; Pernaute R; Laviades C; Virto R; Vicente de Vera C
Nefrologia; 2006; 26(1):84-97. PubMed ID: 16649429
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
[TBL] [Abstract][Full Text] [Related]
10. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
[TBL] [Abstract][Full Text] [Related]
11. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.
Böhm V; Tiroke K; Schneider S; Sperschneider H; Stein G; Bitsch R
Int J Vitam Nutr Res; 1997; 67(4):262-6. PubMed ID: 9285256
[TBL] [Abstract][Full Text] [Related]
12. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
[TBL] [Abstract][Full Text] [Related]
13. [Lipoprotein oxidation profile in end stage renal disease patients. Role of vitamin C supplementation].
Ramos R; Gómez-Geriqué N; Martínez-Castelao A
Nefrologia; 2005; 25(2):178-84. PubMed ID: 15912655
[TBL] [Abstract][Full Text] [Related]
14. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study.
Sirover WD; Siddiqui AA; Benz RL
Ren Fail; 2008; 30(9):884-9. PubMed ID: 18925528
[TBL] [Abstract][Full Text] [Related]
15. Infective endocarditis in maintenance hemodialysis patients: fifteen years' experience in one medical center.
Chang CF; Kuo BI; Chen TL; Yang WC; Lee SD; Lin CC
J Nephrol; 2004; 17(2):228-35. PubMed ID: 15293522
[TBL] [Abstract][Full Text] [Related]
16. Lipoperoxidation and hemodialysis.
Ramos R; Martínez-Castelao A
Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
[TBL] [Abstract][Full Text] [Related]
17. Vitamins and quality of life in hemodialysis patients.
Mydlik M; Derzsiová K
J Nephrol; 2008; 21 Suppl 13():S129-33. PubMed ID: 18446746
[TBL] [Abstract][Full Text] [Related]
18. Low cholesterol along with inflammation predicts morbidity and mortality in hemodialysis patients.
Tsirpanlis G; Boufidou F; Zoga M; Triantafyllis G; Fatourou A; Stamatelou K; Bleta A; Petrihou C; Chatzipanagiotou S; Nicolaou C
Hemodial Int; 2009 Apr; 13(2):197-204. PubMed ID: 19432694
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
20. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
